HERON THERAPEUTICS INC

Ticker: HRTX CUSIP: 427746102 Class: COM

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's Holding History (CIK: 0001132716)

Note: Option positions (PUT/CALL) are excluded.

Q2 2022
Shares 10,145,000 Value ($000) $28,305,000 Avg Close $4.02 Range $2.19 - $6.38
Q4 2021
Shares 8,275,000 Value ($000) $75,551,000 Avg Close $10.21 Range $8.23 - $12.79
Q3 2021
Shares 6,633,916 Value ($000) $70,917,000 Avg Close $12.17 Range $10.10 - $16.16
Q2 2021
Shares 4,425,000 Value ($000) $68,676,000 Avg Close $15.91 Range $12.96 - $18.99
Q1 2021
Shares 2,325,000 Value ($000) $37,688,000 Avg Close $17.83 Range $14.34 - $21.64
Q4 2020
Shares 600,000 Value ($000) $12,699,000 Avg Close $17.38 Range $14.43 - $22.40
Q3 2020
Shares 650,000 Value ($000) $9,633,000 Avg Close $15.60 Range $13.13 - $18.18
Q2 2020
Shares 675,000 Value ($000) $9,929,000 Avg Close $16.43 Range $10.81 - $22.19
Q1 2020
Shares 1,400,000 Value ($000) $16,436,000 Avg Close $18.80 Range $9.60 - $24.76
Q2 2019
Shares 100,000 Value ($000) $1,859,000 Avg Close $19.98 Range $16.20 - $26.59